Hormone therapy may reduce kyphosis development — 3 takeaways

The Women’s Health Initiative researchers investigated the impact of hormone therapy on hyperkyphosis development.

Advertisement

The study encompassed 9,700-plus women aged 65 years or older within a 15-year timeframe.

 

Menopause published the study.

 

Here are three takeaways:

 

1. The women who reported continuous or remote past hormone therapy developed less-pronounced kyphosis by their mid-80s compared to the nonusers.

 

2. Researchers concluded their findings support hormone therapy as a potential postmenopause treatment for those women who may develop fractures or posture abnormalities.

 

3. Further, the benefits of hormone therapy continued beyond treatment.

 

More articles on spine:
NuVasive’s SpineTRACK Registry participants can now earn Medicare payment incentives — 3 insights
Spine surgery for professional athletes: Which technique is best? 5 key findings
Dr. Roger Sung reducing opioid dependency after spine surgery: 5 key points

 

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spine

Advertisement

Comments are closed.